Eramet S.A (ERA) | Financial Analysis & Statements
Eramet S.A. Large-cap Basic Materials
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Income Metrics
Balance Sheet Metrics
Total Assets
5.9B
Total Liabilities
1.4B
Shareholders Equity
1.5B
Debt to Equity
0.96
Cash Flow Metrics
Revenue & Profitability Trend
Annual Income Flow
2025
Eramet S.A Income Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2.8B | 2.9B | 3.3B | 5.1B | 3.7B |
| Cost of Goods Sold | 1.3B | 1.2B | 1.3B | 1.8B | 1.2B |
| Gross Profit | 1.5B | 1.7B | 1.9B | 3.3B | 2.5B |
| Gross Margin % | 53.4% | 58.4% | 58.8% | 65.4% | 67.1% |
| Operating Expenses | |||||
| Research & Development | 15.0M | 22.0M | 44.0M | 17.0M | 21.0M |
| Selling, General & Administrative | - | - | - | - | 1.1B |
| Other Operating Expenses | 1.1B | 1.2B | 1.3B | 1.4B | 1.2B |
| Total Operating Expenses | 1.1B | 1.2B | 1.4B | 1.5B | 2.3B |
| Operating Income | -195.0M | 70.0M | 39.0M | 1.3B | 764.0M |
| Operating Margin % | -7.1% | 2.4% | 1.2% | 24.9% | 20.6% |
| Non-Operating Items | |||||
| Interest Income | 12.0M | 37.0M | 41.0M | 8.0M | 9.0M |
| Interest Expense | 164.0M | 174.0M | 150.0M | 116.0M | 114.0M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -525.0M | 41.0M | 105.0M | 1.2B | 888.0M |
| Income Tax | 43.0M | 94.0M | 88.0M | 264.0M | 98.0M |
| Effective Tax Rate % | 0.0% | 229.3% | 83.8% | 22.1% | 11.0% |
| Net Income | -570.0M | -52.0M | 18.0M | 774.0M | 365.0M |
| Net Margin % | -20.7% | -1.8% | 0.6% | 15.2% | 9.8% |
| Key Metrics | |||||
| EBITDA | 331.0M | 379.0M | 984.0M | 2.1B | 1.0B |
| EPS (Basic) | - | €0.50 | €3.79 | €25.81 | €10.42 |
| EPS (Diluted) | - | €0.50 | €3.79 | €25.49 | €10.37 |
| Basic Shares Outstanding | - | 28623741 | 28759894 | 28674721 | 28571634 |
| Diluted Shares Outstanding | - | 28623741 | 28759894 | 28674721 | 28571634 |
Income Statement Trend
Eramet S.A Balance Sheet From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 568.0M | 631.0M | 1.1B | 1.1B | 789.0M |
| Short-term Investments | 23.0M | 282.0M | 522.0M | 537.0M | 387.0M |
| Accounts Receivable | 225.0M | 217.0M | 221.0M | 369.0M | 375.0M |
| Inventory | 648.0M | 692.0M | 619.0M | 724.0M | 578.0M |
| Other Current Assets | - | - | - | - | - |
| Total Current Assets | 2.0B | 2.4B | 3.0B | 4.0B | 3.1B |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.8B | 636.0M | 656.0M | 477.0M | 417.0M |
| Goodwill | 318.0M | 526.0M | 516.0M | 583.0M | 567.0M |
| Intangible Assets | 20.0M | 152.0M | 144.0M | 167.0M | 155.0M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | -1.0M | 4.0B | -2.0M | - | 1.0M |
| Total Non-Current Assets | 3.9B | 4.1B | 3.3B | 3.2B | 3.1B |
| Total Assets | 5.9B | 6.5B | 6.3B | 7.2B | 6.2B |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 371.0M | 384.0M | 445.0M | 424.0M | 403.0M |
| Short-term Debt | 495.0M | 341.0M | 621.0M | 536.0M | 468.0M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | 193.0M | 254.0M | 177.0M | 135.0M | 143.0M |
| Total Current Liabilities | 1.4B | 1.5B | 1.8B | 2.5B | 2.1B |
| Non-Current Liabilities | |||||
| Long-term Debt | 2.0B | 1.9B | 1.6B | 1.5B | 1.6B |
| Deferred Tax Liabilities | 184.0M | 251.0M | 246.0M | 270.0M | 225.0M |
| Other Non-Current Liabilities | 1.0M | 8.0M | 1.0M | 7.0M | 2.0M |
| Total Non-Current Liabilities | 2.9B | 2.9B | 2.5B | 2.4B | 2.8B |
| Total Liabilities | 4.4B | 4.3B | 4.3B | 4.9B | 4.9B |
| Equity | |||||
| Common Stock | 88.0M | 88.0M | 88.0M | 88.0M | 88.0M |
| Retained Earnings | - | - | - | - | - |
| Treasury Stock | - | - | - | - | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 1.5B | 2.1B | 2.0B | 2.2B | 1.3B |
| Key Metrics | |||||
| Total Debt | 2.5B | 2.2B | 2.2B | 2.0B | 2.1B |
| Working Capital | 536.0M | 941.0M | 1.2B | 1.5B | 969.0M |
Balance Sheet Composition
Eramet S.A Cash Flow Statement From 2021 to 2025
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -570.0M | -52.0M | 18.0M | 774.0M | 365.0M |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | -102.0M | -66.0M | 55.0M | -90.0M | -152.0M |
| Operating Cash Flow | -661.0M | -110.0M | 48.0M | 718.0M | 204.0M |
| Investing Activities | |||||
| Capital Expenditures | -428.0M | -599.0M | -914.0M | -581.0M | 2.0M |
| Acquisitions | 0 | 0 | 0 | 37.0M | 0 |
| Investment Purchases | - | - | - | - | - |
| Investment Sales | - | - | - | - | - |
| Investing Cash Flow | -438.0M | -629.0M | -718.0M | -554.0M | -359.0M |
| Financing Activities | |||||
| Share Repurchases | - | -5.0M | -10.0M | -7.0M | -8.0M |
| Dividends Paid | -43.0M | -43.0M | -100.0M | -72.0M | -4.0M |
| Debt Issuance | 474.0M | 847.0M | 1.4B | 167.0M | 120.0M |
| Debt Repayment | -243.0M | -502.0M | -1.1B | -398.0M | -1.2B |
| Financing Cash Flow | 501.0M | 27.0M | 356.0M | 139.0M | -900.0M |
| Free Cash Flow | -742.0M | -727.0M | -748.0M | 403.0M | 643.0M |
| Net Change in Cash | -598.0M | -712.0M | -314.0M | 303.0M | -1.1B |
Cash Flow Trend
Eramet S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
105.50
Forward P/E
9.08
Price to Book
2.08
Price to Sales
0.54
PEG Ratio
9.08
Profitability Ratios
Profit Margin
-17.10%
Operating Margin
-7.74%
Return on Equity
-31.37%
Return on Assets
-2.06%
Financial Health
Current Ratio
1.37
Debt to Equity
168.90
Beta
0.91
Per Share Data
EPS (TTM)
€-16.67
Book Value per Share
€25.19
Revenue per Share
€97.49
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| ERA | 1.6B | 105.50 | 2.08 | -31.37% | -17.10% | 168.90 |
| ZCCM Investment | 424.6M | 0.24 | 0.01 | -32.88% | -15.16% | 0.06 |
| ZCI Limited | 11.1M | 2.50 | - | 0.00% | 0.00% | - |
Financial data is updated regularly. All figures are in the company's reporting currency.